Aling Shen
Impact in
- Pharmacology top 2%
- Flavonoids in Medical Research
- Pharmacological Effects of Natural Compounds
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Natural product bioactivities and synthesis 8
- Metabolomics and Mass Spectrometry Studies 7
- RNA modifications and cancer 6
- Oncology 26
- Cancer-related Molecular Pathways 12
- Cancer Cells and Metastasis 8
- Co-authors
- Jun Peng (55 shared papers)Youqin Chen (50 shared papers)Jiumao Lin (19 shared papers)Thomas J. Sferra (35 shared papers)Liya Liu (38 shared papers)Qiaoyan Cai (14 shared papers)Zhenfeng Hong (13 shared papers)Lihui Wei (21 shared papers)
- Journals
- Oncology Reports (8 papers)Chinese Journal of Integrative Medicine (7 papers)Biomedicine & Pharmacotherapy (6 papers)Evidence-based Complementary and Alternative Medicine (5 papers)Frontiers in Pharmacology (5 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Aling Shen
97 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 95
- Pharmacology 188
- Complementary and alternative medicine 175
- Cancer Research 305
- Pharmacology 258
- Oncology 386
Countries citing papers authored by Aling Shen
This map shows the geographic impact of Aling Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aling Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aling Shen more than expected).
Fields of papers citing papers by Aling Shen
This network shows the impact of papers produced by Aling Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aling Shen. The network helps show where Aling Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Aling Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 71 | |
| 2 | 2012 | 63 | |
| 3 | 2012 | 60 | |
| 4 | 2019 | 56 | |
| 5 | 2015 | 42 | |
| 6 | 2012 | 38 | |
| 7 | 2019 | 38 | |
| 8 | 2014 | 37 | |
| 9 | 2013 | 37 | |
| 10 | 2016 | 35 | |
| 11 | 2015 | 35 | |
| 12 | 2012 | 34 | |
| 13 | 2017 | 33 | |
| 14 | 2014 | 33 | |
| 15 | 2013 | 32 | |
| 16 | 2013 | 32 | |
| 17 | 2013 | 31 | |
| 18 | 2015 | 29 | |
| 19 | 2018 | 28 | |
| 20 | 2018 | 27 |
About Aling Shen
Aling Shen is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 101 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Cancer, Hypoxia, and Metabolism (8 papers), Flavonoids in Medical Research (8 papers), Natural product bioactivities and synthesis (8 papers), Cancer Cells and Metastasis (8 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Traditional Chinese Medicine Analysis (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Pharmacology (188 citations), Complementary and alternative medicine (175 citations), Cancer Research (305 citations), Pharmacology (258 citations) and Oncology (386 citations). Aling Shen has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jun Peng, Youqin Chen, Jiumao Lin, Thomas J. Sferra, Liya Liu, Qiaoyan Cai, Zhenfeng Hong, Lihui Wei, Lihui Wei and Jianfeng Chu. Their work appears in journals such as Oncology Reports, Chinese Journal of Integrative Medicine, Biomedicine & Pharmacotherapy, Evidence-based Complementary and Alternative Medicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.